Attovia Therapeutics
Angie You is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as an Independent Board Member at Attovia Therapeutics and a Senior Advisor at Frazier Healthcare Partners, Angie You has held various influential roles including Chief Executive Officer at Architect Therapeutics and Board Member at multiple companies such as ORIC Pharmaceuticals Inc. and RayzeBio. Previous experience includes key leadership positions at Amunix Pharmaceuticals as CEO and at Sierra Oncology as Chief Business and Strategy Officer. Angie You's educational background includes both an AB and PhD in Chemistry and Biochemistry from Harvard University.
This person is not in the org chart
This person is not in any teams
Attovia Therapeutics
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement. The biparatopic binding mode of ATTOBODIES translates to picomolar affinity with glue-like off-rates, exquisite specificity, and accelerated target internalization. Their small format and modularity offer fast tissue penetration, ease of engineering into bispecifics, and tunable half-life from hours to weeks. Collectively, these properties of ATTOBODIES expand the addressable target and epitope universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile compared to traditional approaches. By utilizing our ATTOBODY technology, we will develop novel medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We envision a world where no patient is left behind.